We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+6.65%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$341M
AUM Growth
+$7.46M
Cap. Flow
-$14M
Cap. Flow %
-4.12%
Top 10 Hldgs %
56.58%
Holding
359
New
34
Increased
32
Reduced
64
Closed
30
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UFOX
351
Defiance Space and Connective Tech ETF
UFOX
$911M
-11,040
Closed -$301K
CPE
352
DELISTED
Callon Petroleum Company
CPE
$0 ﹤0.01%
17
-1
-6% -$9
POTX
353
DELISTED
Global X Cannabis ETF
POTX
0
RDS.A
354
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-1,540
Closed -$50K
PRSP
355
DELISTED
Perspecta Inc. Common Stock
PRSP
$0 ﹤0.01%
17
LOGM
356
DELISTED
LogMein, Inc.
LOGM
-74
Closed -$6K
GSB
357
DELISTED
GlobalSCAPE, Inc.
GSB
-50
Closed
MLNX
358
DELISTED
Mellanox Technologies, Ltd.
MLNX
-8
Closed -$1K
CIT
359
DELISTED
CIT Group Inc.
CIT
-27
Closed -$1K

Similar funds

Roble Belko & Company's Q3 2020 Portfolio in Review

As of Q3 2020, Roble Belko & Company held 359 positions worth $341M, up 2.2% from $334M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Roble Belko & Company withdrew a net $14M in Q3 2020, closing 30 positions and reducing 64 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $303K position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.2% of assets, up from 2% a quarter earlier, followed by Technology and Industrials.

Against the trend, Roble Belko & Company opened a new position in Vanguard Morningstar Mid-Cap Growth ETF worth $284K.

  • Roble Belko & Company's largest Q3 2020 buy was Vanguard Morningstar Mid-Cap Growth ETF: 1,578 shares worth $284K.
  • Roble Belko & Company added most to Vanguard Short-Term Inflation-Protected Securities Index Fund in Q3 2020, an estimated $1.4M increase.
  • Roble Belko & Company's biggest Q3 2020 reduction was Global X MLP & Energy Infrastructure ETF, cutting an estimated $2.31M.
  • Roble Belko & Company fully exited State Street SPDR S&P Biotech ETF in Q3 2020, selling an estimated $303K.
  • Roble Belko & Company's ten largest holdings make up 57% of its $341M portfolio in Q3 2020.
  • Roble Belko & Company opened 34 new positions and closed 30 in Q3 2020.
  • Roble Belko & Company's portfolio value rose 2.2% quarter-over-quarter to $341M.

Based on Roble Belko & Company's 13F filing for Q3 2020, filed 10 Nov 2020.